Adjunctive olanzapine treatment in bipolar adolescents responding insufficiently to mood stabilizers: Four case reports

European Child and Adolescent Psychiatry

Volumn 15, Issue 8, 2006, Pages 500-503

  Emiroglu, F Neslihan Inal ^a   Gencer, Özlem ^a   Özbek, Aylin ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Adolescent; Bipolar; Disorder; Olanzapine

Indexed keywords

MOOD STABILIZER; OLANZAPINE;

ADJUVANT THERAPY; ADOLESCENT; ARTICLE; BIPOLAR I DISORDER; CASE REPORT; CLINICAL GLOBAL IMPRESSION SCALE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHILD; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE;

EID: 33845893848     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-006-0552-5     Document Type: Article

References (13)

1. Tollefson GD, Sanger TM, Lu MK, Thiema ME (1998) Depressive signs and symptoms in schizophrenia - a prospective blinded trial of olanzapine and halloperidol. Arch Gen Pscyhiatry 55: 250-258
2. Tohen M, Sanger T, Tollefson GD, Mc Elroy SL (1997) Olanzapine versus halloperidol in the treatment of schizoaffective bipolar patients. In: Annual Meeting New Research Program and Abstracts. American Psychiatric Association, Washington, DC, pp 123-124
3. Tohen M, Jacobs TG, Meyers TM (2000) Efficacy of olanzapine combined with mood stabilizers in the treatment of bipolar disorder. Program and Abstracts of the 153rd Annual American Psychiatric Association Meeting May 13-18, Chicago, Illinois
4. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Tomo V ,Rater M, Tarazi RA (2001) A prospective open-label treatment trial of olanzapine monothreapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250
5. Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J (2005) Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-aged children. Biol Psychiatry 58:589-594
6. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensivity. Br J Psychiatry 133:429-435
7. Guy W (1976) ECDEU Assesment Manual for Psychopharmacology. Revised: US Department of Health, Education and Welfare, Rockville, MD
8. Vieta E, Reinares M, Corbella B, Benabarre A, Gilaberte I, Colom F, Martinez-Aran A, Gasto C, Tohen M (2001) Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. J Clin Psychopharmacol 21:469-473
9. Wozniak J, Biederman J, Mundy E, Mennin D, Faraone V (1995) A pilot family study of childhood-onset mania. J Am Acad Child Adolesc Psychiatry 34:1577-1583
10. Tohen M, Sanger TM, Mc Elroy SL, Tollefson GD, Chengappe RKN (1999) Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 156:702-709
11. Tohen M, Jacobs T, Grundy SL, Mc Elroy SL, Banov MC, Janicak PG, Sanger TM, Risser G, Zhang F, Toma V (2000) Efficacy of olanzapine in acute bipolar mania; a double-blind placebo controlled study. The olanzipine HGGW study group. Arch Gen Pscyhiatry 57:841-849
12. Tohen M, Chengappa KNR, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR (2004) Relapse prevention in bipolar I disorder: 18 month comparison of olanzapine plus mood stabiliser versus mood stabiliser alone. Br J Psychiatry 184:337-345
13. Kane JM (1999) Tardive dyskinesia in affective disorders. J Clin Psychiatry 60:43-47